Department of Radiotherapy, University Hospital Gasthuisberg, Leuven, Belgium.
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1172-8. doi: 10.1016/j.ijrobp.2012.09.022. Epub 2012 Nov 10.
Strain rate imaging (SRI) is a new echocardiographic modality that enables accurate measurement of regional myocardial function. We investigated the role of SRI and troponin I (TnI) in the detection of subclinical radiation therapy (RT)-induced cardiotoxicity in breast cancer patients.
This study prospectively included 75 women (51 left-sided and 24 right-sided) receiving adjuvant RT to the breast/chest wall and regional lymph nodes. Sequential echocardiographs with SRI were obtained before RT, immediately after RT, and 8 and 14 months after RT. TnI levels were measured on the first and last day of RT.
Mean heart and left ventricle (LV) doses were both 9 ± 4 Gy for the left-sided patients and 4 ± 4 Gy and 1 ± 0.4 Gy, respectively, for the right-sided patients. A decrease in strain was observed at all post-RT time points for left-sided patients (-17.5% ± 1.9% immediately after RT, -16.6% ± 1.4% at 8 months, and -17.7% ± 1.9% at 14 months vs -19.4% ± 2.4% before RT, P<.01) but not for right-sided patients. When we considered left-sided patients only, the highest mean dose was given to the anterior left ventricular (LV) wall (25 ± 14 Gy) and the lowest to the inferior LV wall (3 ± 3 Gy). Strain of the anterior wall was reduced after RT (-16.6% ± 2.3% immediately after RT, -16% ± 2.6% at 8 months, and -16.8% ± 3% at 14 months vs -19% ± 3.5% before RT, P<.05), whereas strain of the inferior wall showed no significant change. No changes were observed with conventional echocardiography. Furthermore, mean TnI levels for the left-sided patients were significantly elevated after RT compared with before RT, whereas TnI levels of the right-sided patients remained unaffected.
In contrast to conventional echocardiography, SRI detected a regional, subclinical decline in cardiac function up to 14 months after breast RT. It remains to be determined whether these changes are related to clinical outcome. In the meantime, we encourage the use of radiation techniques that minimize the exposure of the anterior LV wall in left-sided patients.
应变率成像(SRI)是一种新的超声心动图技术,可准确测量局部心肌功能。我们研究了 SRI 和肌钙蛋白 I(TnI)在检测乳腺癌患者亚临床放射治疗(RT)诱导的心脏毒性中的作用。
本研究前瞻性纳入 75 例接受乳腺/胸壁和区域淋巴结辅助 RT 的女性(左侧 51 例,右侧 24 例)。在 RT 前、RT 后即刻以及 RT 后 8 个月和 14 个月时进行 SRI 连续超声心动图检查。在 RT 的第一天和最后一天测量 TnI 水平。
左侧患者的心脏和左心室(LV)平均剂量均为 9 ± 4 Gy,右侧患者分别为 4 ± 4 Gy 和 1 ± 0.4 Gy。左侧患者在所有 RT 后时间点的应变均下降(RT 后即刻 -17.5% ± 1.9%,8 个月时 -16.6% ± 1.4%,14 个月时 -17.7% ± 1.9%,与 RT 前相比,均 P<.01),但右侧患者无变化。仅考虑左侧患者时,LV 前壁的平均剂量最高(25 ± 14 Gy),而 LV 下壁的剂量最低(3 ± 3 Gy)。RT 后,前壁应变降低(RT 后即刻 -16.6% ± 2.3%,8 个月时 -16% ± 2.6%,14 个月时 -16.8% ± 3%,与 RT 前相比,均 P<.05),而下壁应变无明显变化。常规超声心动图无变化。此外,与 RT 前相比,左侧患者的平均 TnI 水平在 RT 后显著升高,而右侧患者的 TnI 水平保持不变。
与常规超声心动图相比,SRI 在 RT 后 14 个月检测到心脏功能的区域性、亚临床下降。这些变化是否与临床结果有关仍有待确定。在此期间,我们鼓励使用可最大程度减少左侧患者 LV 前壁暴露的放射技术。